What the company does
RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. The company human products portfolio includes tegoprazan for gastroesophageal reflux disease; and grapiprant for cancer and pain management; RQ-00000008 for the treatment of osteoarthritis autoimmune disorders; RQ-00000010 to treat gastroparesis. It also provides veterinary products, such as capromorelin to treat anorexia in dogs and weight management in cats; grapiprant for osteoarthritis in dogs; RQ-00000008 to treat osteoarthritis and others; RQ-00317076 for pain; and RQ-00000010 for gut motility disorders, gastroparesis, functional dyspepsia, and chronic constipation. In addition, it provides RQ-00433412 for constipation, and …
What the weekly tape is saying
4579 closed the latest completed week at 459.0 JPY. The 4-week return is -35.7% and the 12-week return is -44.9%. Trend Signal is inactive, Market Dynamics is -1.26. Setup signature: Risk-first tape with a 18/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 879.2 JPY
- Vs Trend Line
- -47.8%
- Fair Value
- 633.0 JPY
- Vs Fair Value
- -27.5%
- 52W High
- 1,465 JPY
- 52W Low
- 440.0 JPY
- Drawdown
- -68.7%
- Range Position
- 1.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 39
- 52W Active Breadth
- 75.0%
- Sector Scope
- JP Healthcare
- Sector Rank
- 180 of 223
- Sector Percentile
- 19.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
JP Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -3.4%
- Trend Breadth
- 27.0%
- Positive MD
- 28.0%
JP Biotechnology
- Tracked Peers
- 48
- 4W Rank
- 47 of 48
- Avg 1W
- -6.1%
- Avg 4W
- -16.7%
- Trend Breadth
- 12.5%
- Positive RS
- 2.1%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.26
- 4W MD Change
- -9.0%
- Relative Strength
- -52.25
- 4W RS Change
- -121.5%
- Expectation
- Negative
- Probability
- 43.25%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.2M
- 13W Average
- 1.2M
- 52W Average
- 2.5M
- Vs 13W
- 1.0x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.4%
- 52W Volatility
- 9.9%
- Upside Weeks
- 21
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 8.0% / -5.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- JPX
- Country
- JP
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- JPY
- Market Cap
- 13.0B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 459.0 JPY | -6.3% | 879.2 JPY | 633.0 JPY | -1.26 | -52.25 | 1.2M | Off |
| 5 Jun 2026 | 490.0 JPY | -2.2% | 881.2 JPY | 635.0 JPY | -1.26 | -50.09 | 1.7M | Off |
| 29 May 2026 | 501.0 JPY | -12.4% | 881.1 JPY | 637.0 JPY | -1.22 | -49.38 | 1.7M | Off |
| 22 May 2026 | 572.0 JPY | -19.9% | 882.1 JPY | 638.8 JPY | -1.19 | -40.18 | 2.6M | Off |
| 15 May 2026 | 714.0 JPY | -10.2% | 880.9 JPY | 640.2 JPY | -1.16 | -23.59 | 896.4K | Off |
| 8 May 2026 | 795.0 JPY | 0.1% | 874.5 JPY | 640.5 JPY | -1.06 | -16.72 | 227.5K | Off |
| 1 May 2026 | 794.0 JPY | -1.1% | 866.9 JPY | 640.5 JPY | -1.03 | -12.24 | 458.2K | Off |
| 24 Apr 2026 | 803.0 JPY | -6.2% | 860.1 JPY | 640.5 JPY | -1.02 | -11.33 | 643.0K | Off |
| 17 Apr 2026 | 856.0 JPY | 4.3% | 852.6 JPY | 640.5 JPY | -1.02 | -3.25 | 882.2K | Off |
| 10 Apr 2026 | 821.0 JPY | 3.8% | 843.7 JPY | 640.3 JPY | -1.10 | -4.15 | 834.9K | Off |
| 3 Apr 2026 | 791.0 JPY | -4.6% | 835.4 JPY | 640.5 JPY | -1.12 | -0.47 | 927.5K | Off |
| 27 Mar 2026 | 829.0 JPY | -0.5% | 828.3 JPY | 640.8 JPY | -1.02 | 4.46 | 2.1M | On |
| 20 Mar 2026 | 833.0 JPY | -4.6% | 819.0 JPY | 640.9 JPY | -0.87 | 5.66 | 757.5K | On |
| 13 Mar 2026 | 873.0 JPY | -2.9% | 809.2 JPY | 640.8 JPY | -0.63 | 10.55 | 1.4M | On |